Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2020-01-14 2019-11-28
Drug Identification Number 02312441 02312441
Brand name PRADAXA PRADAXA
Common or Proper name Pradaxa Pradaxa
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE
Strength(s) 110MG 110MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 60's 60's
ATC code B01AE B01AE
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-11-29 2019-11-29
Estimated end date 2020-01-15 2019-12-12
Actual end date 2020-01-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments